Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Certified by Founder
Lodge
StimOxyGen
start up
United Kingdom
- Coleraine, Derry
- 12/03/2025
- Unknown
- $1,939,450
StimOxyGen is a proprietary and world-leading innovative approach to address the global challenge of tumour hypoxia.
Hypoxia, or lack of oxygen, is a common characteristic of solid tumours that contributes to the failure of many types of cancer treatment, particularly radiotherapy which relies on oxygen for maximum efficacy.
We can solve this longstanding major unmet clinical need by fueling tumours with oxygen to maximise therapeutic effects of radiotherapy.
- Industry Research Services
- Website https://stimoxygen.com/
- LinkedIn https://www.linkedin.com/company/stimoxygen/
Related People
Sian FarrellFounder
United Kingdom -
Londonderry, Northern Ireland
Co-founder and Chief Executive Officer at StimOxyGen.
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)